26 Oct 2016
Exchange in Endocrinology Expertise
Novo Nordisk, Novartis & the Section/Board of Endocrinology of the UEMS
ln order to facilitate within Europe the exchange of trainees specialising in adult Endocrinology and to harmonise and improve the training of endocrinologists, the Section/Board of Endocrinology of the UEMS and Novo Nordisk A/S and Novartis have set up a fellowship program called '3E', the Exchange in Endocrinology Expertise.
The Exchange in Endocrinology Expertise program will support candidates for an assignment in a leading centre in Endocrinology, Diabetes and Metabolism in Europe. The task will include both clinical practice and research.
Depending on the requirement of each individual project the duration of assignment may last up to six months. Whenever possible, the assignment should include both clinical practice and research. Publication should be sought, and if not relevant a report has to be submitted at the end.
The maximum support is EUR 18.000 for six months or the respective aliquot for shorter exchange periods.
The selection of the candidates will be done by a Committee from the Section/Board of Endocrinology.
The criteria for a candidate to be selected are the following:
The country of origin as well as the receiving centre might be any of the countries represented in the UEMS Section/Board of Endocrinology.
The budget for the fellowship is limited to 18.000 EUR and can be used to cover salary, travel expenses (one return trip) and potential research expenses like bench fees.
The fellowship applications should be sent by e-mail to the following address before December 9th. 2016:
Prof. Anton Luger, MD
President, UEMS Section/Board of Endocrinology
Division of Endocrinology and Metabolism
Department of Medicine III
Medical University and General Hospital of Vienna
Waehringer Guertel 18-20
1090 Vienna
Austria
Email: [email protected]
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024